Aadi Global holds exclusive rights for products of pharmaceutical excipient and API manufacturers for North & South America & the EU. The excipients (superdisintegrants) that can be made available include Sodium Starch Glycollate, Croscarmellose Sodium, Polacrillin Potassium, Calcium carboxymethylcellulose to name a few. We also formulate and distribute Nutraceuticals and some select intermediates like 4-dimethyl amino benzaldehyde, 4-dimethylamino cinnamaldehyde, indicator chemicals for laboratory use.
Ahn-Gook Pharmaceutical Co., Ltd. is a leading pharmaceutical company in Korea, we're especially strong to Repiratory system and Cardiovascular disease.
Our product, Synatura Syrup is a new drug and No. 1 of antitussive products in Korea, we're already under registration over the 10 countries.
We are accululating core technology to develop new world-class medicine and fostering key manpower that can develop and market our new products.
AAI Pharma Services Corp. and Cambridge Major Laboratories, Inc. have joined to form Alcami, a world class supplier of comprehensive pharmaceutical development and manufacturing services. With seven sites across the globe, our combined capabilities include API development and manufacturing, solid state chemistry, formulation development, analytical development and testing services, clinical and commercial finished dosage form manufacturing (oral solid dose and parenteral), packaging, and stability services.
AllyChem Co Ltd is a fine chemical manufacturing company located in Dalian Economy & Technology Development Zone that specializes in the industrial synthesis of advanced chiral chemicals, diboron esters and multi-functional boronic acids/esters.
Avanti Polar Lipids Inc is the world leader for lipids of unparalleled purity. The company manufactures products for the Research Chemist and cGMP lipids for Pharmaceutical Production. These include phospholipids, sphingolipids, detergents, sterols, polymers, bioactive lipids, chelators plus new Fluorescent and Deuterated lipids. Recent developments include unique Detergents, Adjuvants, Glycosylated Sphingolipids and Kdo2 Lipid A - an Endotoxin replacing LPS. Avanti is the licensed manufacturer of mass spectrometry standards to the LIPID MAPS Initiative. Avanti's extensive Lipid Analysis Department handles Identity Testing, Bioanalytical Lipid Assay and cGLP & 21CFR, part 11 Compliant Analysis. Avanti's clients include the Pharmaceutical & Nutraceutical Industries and Lipid Researchers.
BioVectra is a contract development and manufacturing organization that serves pharmaceutical and biotech companies with full-service cGMP outsourcing solutions for intermediates and active pharmaceutical ingredients (APIs). An innovative and reliable partner with a strong quality history, BioVectra has over 45 years of experience specializing in:
- Microbial Fermentation
- Complex Chemistry
- High-Potency APIs
- Process & Analytical Development
- Drug Development
As one of the leading German manufacturer of ethanol for the pharmaceutical industry, the commitment of BrüggemannAlcohol Heilbronn GmbH is constant, pharmaceutical purity. The company is part of the BrüggemannGroup and is based in Heilbronn since 1868, where ethanol is produced and distributed. Due to the second production site in Wittenberg BrüggemannAlcohol Heilbronn GmbH is able to uphold constant, fast and flexible delivery. In pharmaceutical applications ethanol is used in its purest form in medications, homeopathic products, disinfectants, as well as for extractions of plant-based active substances – from excipient to active pharmaceutical ingredient BrüggemannAlcohol Heilbronn GmbH can offer a wide product portfolio. In order to reach the highest requirements, BrüggemannAlcohol produce ethanol in pharmaceutical qualityaccording to current pharmacopoeia (Ph. Eu.) as well as GMP-quality. Since 2016 the company is certified producer for GMP-ethanol, and offers ethanol in 96% or 100%, undenatured or denatured quality. Packaging is available from 5l cans until loose in tank truck. BrüggemannAlcohol Heilbronn GmbH is looking forward to meeting you on the CPHI 2017 in Frankfurt.
Coral Drugs is an integrated and independent research-based International Pharmaceutical Company that produces a diverse range of high-quality APIs and is headquartered in New Delhi, India. Our API focus covers several therapeutic areas and our facilities are approved by the USFDA, EUGMP and Indian regulatory agencies. At Coral, we believe in maintaining excellent quality standards for our products, services, and quality systems. Our commitment to customers is well-demonstrated by our ability to meet their customized demands and the availability of adequate product documentation such as product DMF's validations, and material/impurity standards. Products include: Active Pharmaceutical Ingredients, API custom manufacturing, Intermediates.
The focus of Enzymicals is to provide integrated solutions for biocatalytic applications. Dedicated to design, develop and implement cost-effective, sustainable and scalable chemo-biocatalytic routes to APIs and intermediates, Enzymicals offers recognized expertise in the use of enzymatic processes for complex chemicals synthesis.
- The independent enterprise provides state of the art SOLUTIONS in development, optimization and piloting of robust chemo-enzymatic processes for the production of fine & specialty chemicals.
- The company manufactures a range of CHEMICALS as chiral building blocks, intermediates and specialty chemicals as well offer custom synthesis on request.
- Enzymicals offers a broad selection of recombinant ENZYMES suitable for research, development, production and diagnostics as well as a tailor-made protein expression and optimization service.
strengths: • source APIs from FDA inspected suppliers • identify contract
manufacturers • purchasing strategies • API development projects • participate
in FDA strategies/submissions/meetings • life cycle management analyses •
product surveillance and stewardship • market and competitive analyses •
portfolio and diversification strategies • due diligence for
Limited, established in 1978, a researched-based acknowledged leading
manufacturers of Preservatives - Parabens, Parabens Formulations and Specialty
Chemicals. We are an ISO 9001:2015 and ISO 14001:2015 certified company.
The company has a very efficient, flexible and local FDA approved manufacturing facility in Ankleshwar, Gujarat (India) with World Class Safety and Environmental Standards. Our core process strength is Carboxylation, Esterification and Etherification and known for various Esters of Para Hydroxy Benzoic Acid and Salicylic Acid.
The products produce by Gujarat Organics are very versatile complying with all the latest pharmacopeia i.e. BP/EP/USP/NF. They are export quality chemical products of specialty nature with best impurity profiles and backed up with after sales technical services.
These products are having applications in various important industries like pharmaceuticals, cosmetics, food processing, flavours and fragrances, dyes, polymers and agrochemicals and have Halal and Star-K Kosher Certification. These products are exported over the years to 72 countries.
We are also specialized in manufacturing below said Electron Donors used in manufacturing Polypropylene:
- Para Ethoxy Ethyl Benzoate (PEEB)
- Para Isopropoxy Ethyl Benzoate (PIPEB)
- Ethyl Benzoate (EP)
Should you need more information about the company, facility and products, please visit our website www.gujaratorganics.com
Reformed from Zhushan Forestry Chemical Industry Factory, Zhushan County Tianxin Medical & Chemical Industry Co Ltd (hereinafter shortened as Tianxin Company) was established in the year of 2001, with register capital of RMB12,000,000 yuan. And it covers an area of 32 Mu (equals to 21344 square meters). The total employees are more than 120, 48 and most of them are technicians.
Taking full advantage of local abundant gallnut resources and adopting advanced technology, Tianxin company becomes a high technology enterprise with strict management and regular operation. Our main products extend to three series including tannic acid, gallic acid, and trimethoxybenzoic acid. The total output value is over 50 million RMB per year and all the products are widely used in many areas, such as minerals, pharmaceuticals, chemicals, agrochem, foods, dyestuffs, electricals, beer, chemistry analysis and petroleum energy etc. Under the scientific management, we use special-purified water and adopt advanced technics, which highly guarantee the low content of heavy metal and iron ion in our products. Then, all products can fully meet the requirement of USP27 and BP98 and other strict export standards.
Since Tianxin set up, we continuously innovate our products and improve our service, sales network. With standardized management, strong capability of independent innovation and reliable quality, we got through ISO9001: 2000 quality system certification in 2002. Besides, we also obtained the right to import and export and got numerous honors in domestic. Now, our products are distributed to Europe, USA, Japan, India and other countries, and are highly recommended by our clients.
As a long–term development strategy, Tianxin Company has established close cooperation with famous institutes and tried to expand the production scale by adopting advanced technology. Now, we are striving to become the largest exporting base of tannic acid and gallic acid in China within 2-3 years. Tianxin Company warmly welcomes your visit and hope we can serve for you!
Olon is an Italian company world leader in the Active Pharmaceutical Ingredients (APIs) production, using synthetic and biological processes for Generic market as well as in Contract Development and Manufacturing (CDMO). Recently the Dossier Unit has been enlarged, considering the development of the Finished Drug Formulations (FDFs) and the preparation of the Common Technical Documents (CTD) dossier.
With a 2017's Turnover of 400 Mio$, Olon supplies 33 Chemical Intermediates (under CMO) and more than 250 APIs (31 under CMO) for the Generic market.
Thanks to 1,500 employees, and to the highly qualified R&D team – more than 200 people – Olon can offer complete integrated packages and services to support the full development of APIs based on strong knowledge in both Chemical and Biological process, all of them under a full cGMP and regulatory coverage – holder of about 130 active US DMFs and 50 granted CoS.
Always considering human safety and environmental security, Olon handles different and not-common manufacturing process technologies, such as Fluorination, Carbonylation and Fermentation.
Headquartered in Rodano (Milan, Italy), Olon has 9 manufacturing facilities – 7 located in Northern Italy, 1 in Spain and 1 in USA – compliant with international requirements, and 3 branch offices: Hamburg (D), Florham Park NJ (USA) and Shanghai (China).
All manufacturing sites are regularly inspected by the most important national and international Authorities, and regularly audited by our partners and customers. All plants are FDA-inspected and self-identified under GDUFA.
Besides pharmaceutical certifications, Olon has dedicated areas for food-grade manufacturing and complies with KOSHER, AHLAL and from 2018-Q2 with FSSC 22.000.
To be highlighted Olon's growing cooperation with Universities: University of Milan (Italy), Milan Politecnico (Italy), University of Pavia (Italy, University of Murcia (Spain), and PROMIDIS (Milan University spin-off).
PCI is an integrated full service provider and a trusted partner to leading companies in the global healthcare industry; we offer unparalleled expertise and experience in taking compounds from the earliest stages of development through to commercial launch, delivering speed to market and commercial success for our customers.
Core services include: Analytical services, formulation development, clinical trial supply, commercial manufacturing and packaging, QP services, supply chain management, storage and distribution. Customers can choose to use us as a complete development partner and benefit from our full range of services or choose any of our core services as a stand-alone offering.
ROBINSON BROTHERS - award-winning UK chemical manufacturer. Offering a portfolio of fine chemicals and rubber accelerators. Business activities include: process research and development, process optimisation, custom/contract manufacturing and scale-up production. Certified to ISO 9001:2015 and FDA approved, our core technology competencies include: Organo-sulfur, Hydrogenation, Amination, Dehydrogenation, Amidation, Heterocyclic chemistries.
Seratec registers DMFs of innovative or generic APIs to the US-FDA or EMEA on behalf of pharmaceutical laboratories, mainly US based. Seratec can handle highly potent APIs in accordance with cGMP (regularly inspected by the US-FDA) from the gr to the ton, from complex, even multi-steps, organic synthesis, essentially within the context of niche markets.Successfully, Seratec was appointed as the main orphans manufacturer for the biggest hospital organization in Europe.Hence, Seratec promotes the talent of its multidisciplinary team, which settles our business by managing efficiently the time required for an approval of our customers' drug applications.
Sumitomo Chemical, incorporating its affiliates Koei Chemical, Sumitomo Seika, and Taoka Chemical, is since several decades an established player in the arena of pharmaceutical chemicals, offering a wide range of products, from API's for originators and generics, over GMP intermediates, regulatory starting materials, and high quality raw materials.
Suven Life Sciences provides services to leading Global Life Science and Fine Chemical majors in the domains of Custom Synthesis, Process R&D, Scale up and Contract Manufacturing of intermediates, APIs and formulations, as part of its Contract Research and Manufacturing Services (CRAMS).
Since its founding in 1989, Suven Life Sciences has established its core competency in the development of small nitrogen containing Heterocycles such as pyrimidines, purines, indoles, and imidazoles. Adding to its renowned expertise in cyanation, Suven has also demonstrated its proficiency in Carbohydrate and Chiral chemistry including pyrroles, tetrahydrofurans, pyrans, amino acids and sulfoxides.
Suven's ability to collaborate on projects at all stages, from route scouting and development at gram scale through to commercial manufacture at multi-ton scale, provides a consistent and reliable partner throughout a product's life cycle and adds value through reduced transition times and tech transfer costs. Suven has two FDA approved cGMP facilities staffed with highly skilled and experienced teams, to meet the regulatory needs of our customers, from Advanced Intermediates to APIs.
Suven Life Sciences is a premier, fully integrated service provider to both Pharmaceutical and Chemical industries, worldwide. Suven has steadily demonstrated the ability to effectively use Its expanding infrastructure in order to contribute to the success of our clients at a different of stages of the drug development process, including the capability to reduce transition times and costs. Suven is dedicated to going beyond commitment and deliver R&D and Manufacturing solutions, with flexibility, quality, speed, and cost effectiveness, through our Contract Research & Manufacturing Services (CRAMS), Drug Discovery & Development Support Services (DDDSS) and Formulation Development Service. These capabilities and dedication have directly resulted in an impressive register of repeat clients, which include leading Global Life Science Majors and top Fine Chemical Companies.
Takasago International Corporation was founded in Japan in 1920. For more than 95 years, Takasago has developed manufacturing technologies to produce ingredients for some of the world's most successful food, beverage, fine fragrance, household and personal care products.
Takasago's ligand and catalyst technologies are available to clients wishing to take advantage of them in their own process design and manufacturing operations. Also being offered is the option of process development and contract manufacturing by Takasago.
Takasago has 120 commercial catalysts specializing in chiral reduction, asymmetric hydrogenation and commercial experience in continuous flow manufacturing of RSMs and GMP Intermediates. Takasago's continuous manufacturing facility is FDA inspected.
Viwit Pharmaceuticals Limited (Viwit), founded in 2006, is a fast-growing research-based pharmaceutical healthcare company dedicated to the development, manufacture and marketing of innovative products in the fields of Finished Dosage Formulations, Active Pharmaceutical Ingredients and Fine Chemicals. Viwit manufactures all the products based on company's core technologies, and is dedicated to serve customers for their greater success and healthier living. Viwit consists of six subsidiaries, including two integrated R&D centers and three cGMP production facilities. It covers a land area of 199,000 ? and employs nearly 500 staffs, including more than 150 scientists, many with PhD or master degrees. All three production facilities are managed under cGMP and ICH quality systems, and are certified respectively by cFDA (Chinese GMP 2010), ISO9000:2008, Mexican COFEPRIS, and World Health Organization. With mission statement of "Innovation for a better life" and culture of "integrity, respect, collaboration and excellence" at heart, Viwit is striving to become a global leading pharmaceutical healthcare company in the development and commercialization of specialty value-added products. Viwit creates values for customers, employees, shareholders and society, and contributes for a healthier and better world.